Non-toxic ionic liquid, preparation method and its application

An ionic liquid and anion technology, applied in pharmaceutical formulations, medical preparations with non-active ingredients, etc., can solve the problems of complex preparation process, toxicity, side effects on human body, etc., and achieve simple preparation process, good solubilization and solubilization, Wide range of effects in the liquid phase

Inactive Publication Date: 2005-08-10
HEBEI NORMAL UNIV
View PDF0 Cites 18 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The most common ionic liquids mentioned above, such as: 1-methyl-3-butylimidazolium hexafluorophosphate, will be hydrolyzed in water to produce volatile and toxic HF and POF 3 , (R.P.Swalowski, J.D.Holbery, and R.D.Rogers, Green Chem., 2003, 5, 361.); 1-methyl-3-butylimidazole tetrafluoroborate its acute toxicity LD 50 =1.4g / kg (female rat), LD 50 =1.37g / kg (male rat) (J.Pernak, et.al., Ind.Eng.Chem.Res.2001, 40, 2379.), therefore, these commonly used ionic liquids all have certain toxicity, Cannot be used in medicine or as a food additive
In addition, in the pharmaceutical industry, there are many drugs that are insoluble in water and are difficult to be absorbed and utilized by the human body. Therefore, solving the solubility of insoluble drugs in water and improving the bioavailability of drugs are still difficult and hot issues in the pharmaceutical industry
The method that is often taken now is to dissolve the drug in the oil phase, and then add a surfactant to make an emulsion or microemulsion to improve the bioavailability of the drug, but this method needs to add a large amount of oil phase, and at the same time, it also needs to add surfactant Some of these additives have side effects on the human body. At the same time, due to the limited types of surfactants and co-solvents, the preparation process is complicated and the cost is high, and it cannot solve the solubility of all insoluble drugs in water.
Up to now, there is no report about ionic liquid as a new solvent, co-solvent or surfactant in the prior art for the preparation of new drug dosage forms or as food additives

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Non-toxic ionic liquid, preparation method and its application
  • Non-toxic ionic liquid, preparation method and its application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0031] Embodiment 1 Preparation of L-lactate choline ionic liquid

[0032] According to the preparation method 1 of ionic liquid, add 9.6ml 90% L-lactic acid solution dropwise to 32ml choline hydroxide 45% methanol solution, stir for 0.5 hour, after purification, evaporate the solvent under high vacuum at 45°C to dryness , to obtain 22.0 g of colorless L-lactate choline ionic liquid.

Embodiment 2

[0033] Example 2 Preparation of DL-lactatecholine ionic liquid

[0034] Synthesis according to the preparation method 1 of ionic liquid: 11.0ml 80% DL-lactic acid solution was added dropwise to 32ml choline hydroxide 45% methanol solution, after stirring for 0.5 hour, after purification, the solvent was evaporated to dryness under high vacuum at 45°C to obtain 22.3 g. Colorless DL-lactate choline ionic liquid.

Embodiment 3

[0035] Example 3 Preparation of Choline Isobutyrate Ionic Liquid

[0036] Synthesis according to the preparation method 1 of ionic liquid: in 20ml of choline hydroxide 45% methanol solution, add 6.14g of isobutyric acid dropwise, after stirring for 0.5 hour, after purification, evaporate the solvent to dryness under high vacuum at 45°C to obtain 15.4 g Colorless choline isobutyrate ionic liquid.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
Particle sizeaaaaaaaaaa
Particle sizeaaaaaaaaaa
Particle sizeaaaaaaaaaa
Login to view more

Abstract

A non-toxic ionic liquid used as the solvent, cosolvent, or surfactant for increasing the water-solubility of the medicines difficult to dissolve in water features that its cation is alkylimidazole salt with short carbon chain or quaternary ammonium salt.

Description

technical field [0001] The invention belongs to the synthesis of new ionic liquid in the field of chemical materials and its manufacture and the application in the field of medicine as a new solvent, co-solvent or surfactant. Background technique [0002] Ionic Liquids (Ionic Liquids) refer to positive ions such as organic alkylimidazoles, quaternary ammonium salts, and alkylpyridines and different negative ions such as chloride ions, BF 4 - , PF 6 - , CF 3 CO 2 - , N(CN) - 2 Many of them are liquid at room temperature or even at low temperature, so they are also called room temperature ionic liquids. Ionic liquids have the characteristics of no vapor pressure, good thermal stability (up to 300-400°C), good electrical conductivity, and are suitable for organic compounds, inorganic compounds, metal organic compounds, gases (H 2 , CO, O 2 etc.) have a wide range of solubility, can be miscible or insoluble with organic solvents, water to form a two-phase or multi-phas...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K47/22
Inventor 刘庆彬张占辉张福军
Owner HEBEI NORMAL UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products